➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Moodys
Express Scripts
Medtronic
Baxter

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Isavuconazole

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Isavuconazole?

Isavuconazole is an investigational drug.

There have been 38 clinical trials for Isavuconazole. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2018.

The most common disease conditions in clinical trials are Aspergillosis, Mycoses, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Basilea Pharmaceutica International Ltd, Astellas Pharma Global Development, Inc., and Astellas Pharma Inc.

There are eighteen US patents protecting this investigational drug and two hundred and forty-seven international patents.

Recent Clinical Trials for Isavuconazole
TitleSponsorPhase
Isavuconazole for the Prevention of COVID-19-associated Pulmonary AspergillosisAstellas Pharma Global Development, Inc.Phase 3
Isavuconazole for the Prevention of COVID-19-associated Pulmonary AspergillosisJeffrey Jenks, MD, MPHPhase 3
Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled TrialAssistance Publique - Hôpitaux de ParisPhase 3

See all Isavuconazole clinical trials

Clinical Trial Summary for Isavuconazole

Top disease conditions for Isavuconazole
Top clinical trial sponsors for Isavuconazole

See all Isavuconazole clinical trials

US Patents for Isavuconazole

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Isavuconazole   Start Trial Azoles for treatment of fungal infections Basilea Pharmaceutica AG, a Swiss Company (Basel, CH)   Start Trial
Isavuconazole   Start Trial N-substituted carbamoyloxyalkyl-azolium derivatives Basilea Pharmaceutica AG (Binningen, CH)   Start Trial
Isavuconazole   Start Trial Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives Basilea Pharmaceutica AG (Basel, CH)   Start Trial
Isavuconazole   Start Trial Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives Basilea Pharmaceutica AG (CH)   Start Trial
Isavuconazole   Start Trial N-phenyl substituted carbamoyloxyalkyl-azolium derivatives Basilea Pharmaceutica AG (CH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Isavuconazole

Drugname Country Document Number Estimated Expiration Related US Patent
Isavuconazole Argentina AR018303 2018-03-06   Start Trial
Isavuconazole Australia AU2931399 2018-03-06   Start Trial
Isavuconazole Morocco MA27677 2018-03-06   Start Trial
Isavuconazole Peru PE03282000 2018-03-06   Start Trial
Isavuconazole World Intellectual Property Organization (WIPO) WO9945008 2018-03-06   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Moodys
Express Scripts
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.